Tenax Therapeutics Files 8-K with Corporate Updates
Ticker: TENX · Form: 8-K · Filed: Jun 17, 2025 · CIK: 34956
| Field | Detail |
|---|---|
| Company | Tenax Therapeutics, INC. (TENX) |
| Form Type | 8-K |
| Filed Date | Jun 17, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, filing, financials
Related Tickers: TENX
TL;DR
TENX filed an 8-K on 6/11/25 covering corporate changes and financials.
AI Summary
On June 11, 2025, Tenax Therapeutics, Inc. filed an 8-K report detailing amendments to its Articles of Incorporation or Bylaws, submission of matters to a vote of security holders, and financial statements and exhibits. The company, formerly known as Oxygen Biotherapeutics, Inc., is incorporated in Delaware and operates in the Pharmaceutical Preparations industry.
Why It Matters
This filing indicates significant corporate actions and disclosures by Tenax Therapeutics, which could impact its governance, shareholder decisions, and financial reporting.
Risk Assessment
Risk Level: low — The filing is a routine corporate disclosure and does not appear to contain any immediate negative news or significant financial distress.
Key Numbers
- 001-34600 — SEC File Number (Identifies the company's filing with the SEC)
- 26-2593535 — EIN (Employer Identification Number for tax purposes)
Key Players & Entities
- TENAX THERAPEUTICS, INC. (company) — Registrant
- Oxygen Biotherapeutics, Inc. (company) — Former Company Name
- June 11, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 2834 (industry_code) — Standard Industrial Classification
FAQ
What specific amendments were made to the Articles of Incorporation or Bylaws?
The filing indicates amendments were made, but the specific details of these amendments are not provided in the provided text excerpt.
What matters were submitted to a vote of security holders?
The filing states that matters were submitted to a vote of security holders, but the nature of these matters is not detailed in the provided text.
What financial statements and exhibits are included in this filing?
The filing mentions the inclusion of financial statements and exhibits, but the specific content is not detailed in the provided text.
When was the company formerly known as Oxygen Biotherapeutics, Inc.?
The company was formerly known as Oxygen Biotherapeutics, Inc. prior to its name change.
What is the Standard Industrial Classification code for Tenax Therapeutics, Inc.?
The Standard Industrial Classification code for Tenax Therapeutics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 17, 2025 regarding TENAX THERAPEUTICS, INC. (TENX).